BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38445358)

  • 21. Loss of p16
    Aesif SW; Aubry MC; Yi ES; Kloft-Nelson SM; Jenkins SM; Spears GM; Greipp PT; Sukov WR; Roden AC
    J Thorac Oncol; 2017 May; 12(5):860-871. PubMed ID: 28179162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Methylation of p16 and hMLH1 genes in esophageal squamous cell carcinoma and reflux esophagitis].
    Wang F; Xie XJ; Piao YS; Liu B; Wang LD
    Zhonghua Bing Li Xue Za Zhi; 2011 Aug; 40(8):537-41. PubMed ID: 22169643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased MET gene copy number negatively affects the survival of esophageal squamous cell carcinoma patients.
    Wang Y; Jiang Z; Xu C; Wang H; Tan L; Su J; Wang X; Jiang D; Hou Y; Song Q
    BMC Cancer; 2019 Mar; 19(1):240. PubMed ID: 30885149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative Molecular Analyses of Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, and Gastric Adenocarcinoma.
    Salem ME; Puccini A; Xiu J; Raghavan D; Lenz HJ; Korn WM; Shields AF; Philip PA; Marshall JL; Goldberg RM
    Oncologist; 2018 Nov; 23(11):1319-1327. PubMed ID: 29866946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stepwise expression of CDKN2A and RB1 proteins in esophageal mucosa from patients at high risk for squamous cell carcinoma.
    Müller LB; Meurer L; Lopes AB; Antunes LC; Vanazzi S; Fagundes RB
    Appl Immunohistochem Mol Morphol; 2014 Oct; 22(9):669-73. PubMed ID: 25046224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrative post-genome-wide association analysis of CDKN2A and TP53 SNPs and risk of esophageal adenocarcinoma.
    Buas MF; Levine DM; Makar KW; Utsugi H; Onstad L; Li X; Galipeau PC; Shaheen NJ; Hardie LJ; Romero Y; Bernstein L; Gammon MD; Casson AG; Bird NC; Risch HA; Ye W; Liu G; Corley DA; Blount PL; Fitzgerald RC; Whiteman DC; Wu AH; Reid BJ; Vaughan TL
    Carcinogenesis; 2014 Dec; 35(12):2740-7. PubMed ID: 25280564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. YAP1 amplification as a prognostic factor of definitive chemoradiotherapy in nonsurgical esophageal squamous cell carcinoma.
    Dai H; Shao YW; Tong X; Wu X; Pang J; Feng A; Yang Z
    Cancer Med; 2020 Mar; 9(5):1628-1637. PubMed ID: 31851786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of copy number alterations in adolescent and adult patients with precursor B acute lymphoblastic leukemia enrolled in PETHEMA protocols.
    Ribera J; Morgades M; Zamora L; Montesinos P; Gómez-Seguí I; Pratcorona M; Sarrà J; Guàrdia R; Nomdedeu J; Tormo M; Martínez-Lopez J; Hernández-Rivas JM; González-Campos J; Barba P; Escoda L; Genescà E; Solé F; Millá F; Feliu E; Ribera JM;
    Cancer; 2015 Nov; 121(21):3809-17. PubMed ID: 26194343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The
    Han M; Yamaguchi S; Onishi M; Fujii T; Hosoya M; Wen X; Kido H; Kato S
    Anticancer Res; 2022 May; 42(5):2277-2288. PubMed ID: 35489754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TP53 and CDKN2a mutations in never-smoker oral tongue squamous cell carcinoma.
    Heaton CM; Durr ML; Tetsu O; van Zante A; Wang SJ
    Laryngoscope; 2014 Jul; 124(7):E267-73. PubMed ID: 24431303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequent genetic aberrations in the cell cycle related genes in mucosal melanoma indicate the potential for targeted therapy.
    Xu L; Cheng Z; Cui C; Wu X; Yu H; Guo J; Kong Y
    J Transl Med; 2019 Jul; 17(1):245. PubMed ID: 31358010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Copy number loss of variation_91720 in PIK3CA predicts risk of esophageal squamous cell carcinoma.
    Wu Y; Liu X; Hu L; Tao H; Guan X; Zhang K; Bai Y; Yang K
    Int J Clin Exp Pathol; 2015; 8(11):14479-85. PubMed ID: 26823766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclin dependent kinase inhibitor 2A/B gene deletions are markers of poor prognosis in Indian children with acute lymphoblastic leukemia.
    Agarwal M; Bakhshi S; Dwivedi SN; Kabra M; Shukla R; Seth R
    Pediatr Blood Cancer; 2018 Jun; 65(6):e27001. PubMed ID: 29446543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multi-region sequencing reveals genetic correlation between esophageal squamous cell carcinoma and matched cell-free DNA.
    Yuan Z; Wang X; Geng X; Li Y; Tan F; Xue Q; Gao S; He J
    Cancer Genet; 2021 Nov; 258-259():93-100. PubMed ID: 34688997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intragenic mutations of CDKN2B and CDKN2A in primary human esophageal cancers.
    Suzuki H; Zhou X; Yin J; Lei J; Jiang HY; Suzuki Y; Chan T; Hannon GJ; Mergner WJ; Abraham JM
    Hum Mol Genet; 1995 Oct; 4(10):1883-7. PubMed ID: 8595411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations of risk factors obesity and occupational airborne exposures with CDKN2A/p16 aberrant DNA methylation in esophageal cancer patients.
    Mohammad Ganji S; Miotto E; Callegari E; Sayehmiri K; Fereidooni F; Yazdanbod M; Rastgar-Jazii F; Negrini M
    Dis Esophagus; 2010 Sep; 23(7):597-602. PubMed ID: 20459442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA copy number profile discriminates between esophageal adenocarcinoma and squamous cell carcinoma and represents an independent prognostic parameter in esophageal adenocarcinoma.
    Rumiato E; Pasello G; Montagna M; Scaini MC; De Salvo GL; Parenti A; Cagol M; Ruol A; Ancona E; Amadori A; Saggioro D
    Cancer Lett; 2011 Nov; 310(1):84-93. PubMed ID: 21757289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus.
    Bian YS; Osterheld MC; Fontolliet C; Bosman FT; Benhattar J
    Gastroenterology; 2002 Apr; 122(4):1113-21. PubMed ID: 11910361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GSTs polymorphisms are associated with epigenetic silencing of CDKN2A gene in esophageal squamous cell carcinoma.
    Forghanifard MM; Aarabi A; Nasiri Aghdam M; Memar B; Hasanzadeh Khayat M; Dadkhah E; Abbaszadegan MR
    Environ Sci Pollut Res Int; 2020 Sep; 27(25):31269-31277. PubMed ID: 32488710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.